Cardiac magnetic resonance offers the promise of radiation-free imaging of the coronary arteries, providing information with respect to luminal stenosis, plaque burden, high-risk plaque characteristics, and disease activity. In combination, this would provide a comprehensive, individualized assessment of coronary atherosclerosis that could be used to improve patient risk stratification and to guide treatment. However, the technical challenges involved with delivering upon this promise are considerable, requiring sophisticated approaches to both data acquisition and post-processing. In this review, we describe the current status of this technology, its capabilities, its limitations, and what will be required in the future to translate this technology into routine clinical practice. (J Am Coll Cardiol Img 2016;9:306-16) 
RATIONALE FOR CMR IMAGING OF THE CORONARY ARTERIES
Magnetic resonance has become a routine clinical imaging investigation used to assess a wide range of Cardiac magnetic resonance potentially allows multifaceted imaging of the coronary arteries, providing information with respect to luminal stenosis on angiographic images, plaque burden on black-blood imaging, high-risk plaque characteristics including high-intensity plaques, and disease activity with hybrid positron emission tomography/magnetic resonance imaging.
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Coronary Imaging With CMR The image shows key characteristics of high-risk coronary plaques and the available cardiac magnetic resonance (CMR) techniques that can be used to identify these features.
with nonobstructive disease (29) and, further, that whole heart black-blood imaging of the coronary vessels in healthy subjects is possible with a novel flow-independent i-T2prep sequence (17) . Simultaneous advances in image analysis will also be required to accurately segment the arterial wall, allowing for rapid plaque burden quantification.
HIGH-RISK ANATOMICAL PLAQUE CHARACTERISTICS.
Histological studies have indicated that culprit plaques responsible for MI have certain pathological characteristics, including a large necrotic core, positive remodeling, a thin fibrous cap, angiogenesis, intraplaque hemorrhage, inflammation, and microcalcification ( Figure 2) . Each of these represents a potential imaging target that might be used to refine our ability to identify high-risk coronary lesions. To better predict an individual person's risk, it will be important to measure not just the plaque burden but also the high-risk plaque burden. Indeed, emerging data have suggested that identification of such characteristics using CT can improve current patient risk stratification models (30) . In the next section, we will review the ability of CMR to identify the specific characteristics that define high-risk plaques. advantage of this technique is that it can be used to acquire information across the entire volume of the heart, ensuring that sampling error is not an issue.
However, T1-weighted imaging of the coronary arteries does not provide detailed anatomical information and so has to be fused with coronary MRA scans, similar to the approach employed for hybrid positron emission tomography (PET) imaging ( Figure 3) . This technique appears effective in the coronary vasculature, with a recent study suggesting a sensitivity and specificity of w90% for thrombus at the site of culprit plaque rupture in patients after MI (36) . Similarly, in a multimodality imaging study of patients with angina, high-intensity plaques on these T1 imaging sequences were associated with multiple high-risk imaging features including subclinical intracoronary thrombus on optical coherence tomography (37), positive remodeling on ultrasound, and low attenuation plaque on CT (38) . 
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The ability to study the activity of specific pathological processes is now with us, heralding the dawn of a new era of cardiovascular molecular imaging. CMR sits at the center of that capability with the availability not only of specific magnetic resonance tracers, but also with the emergence of hybrid PET and MRI systems that can harness the unrivaled sensitivity and availability of PET imaging agents. nagel@cardiac-imaging.org.
